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INTRODUCTION
Infections with the non-Candida yeast species Trichosporon 
have  been  recognised  with  increasing  frequency  over 












abdomen,  pelvis  and  lower  limbs  in  a  farming  accident. 
Following  laparotomy  and  lower  limb  vascular  repair,  he 
was admitted to the regional intensive care unit (ICU) for 
ventilatory and inotropic support where he rapidly developed 
metabolic  acidosis,  coagulopathy  and  acute  renal  failure 
requiring haemodialysis.
The  patient  developed  a  persistent  Enterobacter  cloacae 
bacteraemia despite receiving ciprofloxacin with gentamicin 
and,  subsequently,  meropenem.  In  response  to  continued 
pyrexia  despite  maximal  antibacterial  therapy,  liposomal 






the  patient’s  persistent  pyrexia  and  positive  blood  culture 
isolates.
Blood taken for culture on the fourth day of amphotericin 






















































to  successfully  treat  disseminated  T.  asahii  infection.7 
There is concern however that the cyclodextran excipient 




We  believe  this  to  be  the  first  report  of  T.  asahii  blood-








we  conclude  that  amphotericin  B  cannot  be  considered 
optimal  first  line  therapy  for  the  treatment  of  invasive 
trichosporonosis.9 Furthermore, available evidence suggests 
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